Biocon Statistics
Total Valuation
Biocon has a market cap or net worth of INR 408.95 billion. The enterprise value is 607.42 billion.
Market Cap | 408.95B |
Enterprise Value | 607.42B |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
Earnings Date | Apr 25, 2025 |
Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
Biocon has 1.20 billion shares outstanding. The number of shares has increased by 0.11% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.20B |
Shares Change (YoY) | +0.11% |
Shares Change (QoQ) | -2.89% |
Owned by Insiders (%) | 62.53% |
Owned by Institutions (%) | 22.34% |
Float | 444.31M |
Valuation Ratios
The trailing PE ratio is 50.92 and the forward PE ratio is 56.63. Biocon's PEG ratio is 1.58.
PE Ratio | 50.92 |
Forward PE | 56.63 |
PS Ratio | 2.77 |
PB Ratio | 2.00 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 1.58 |
Enterprise Valuation
EV / Earnings | 75.52 |
EV / Sales | 4.11 |
EV / EBITDA | 18.47 |
EV / EBIT | 43.48 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.63 |
Debt / EBITDA | 5.10 |
Debt / FCF | n/a |
Interest Coverage | 1.53 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 2.03% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 9.05M |
Profits Per Employee | 492,982 |
Employee Count | 16,315 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.85% in the last 52 weeks. The beta is 0.43, so Biocon's price volatility has been lower than the market average.
Beta (5Y) | 0.43 |
52-Week Price Change | +32.85% |
50-Day Moving Average | 350.64 |
200-Day Moving Average | 352.02 |
Relative Strength Index (RSI) | 51.25 |
Average Volume (20 Days) | 2,358,315 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biocon had revenue of INR 147.62 billion and earned 8.04 billion in profits. Earnings per share was 6.71.
Revenue | 147.62B |
Gross Profit | 90.23B |
Operating Income | 14.00B |
Pretax Income | 17.19B |
Net Income | 8.04B |
EBITDA | 32.45B |
EBIT | 14.00B |
Earnings Per Share (EPS) | 6.71 |
Balance Sheet
The company has 26.50 billion in cash and 167.71 billion in debt, giving a net cash position of -141.21 billion or -117.98 per share.
Cash & Cash Equivalents | 26.50B |
Total Debt | 167.71B |
Net Cash | -141.21B |
Net Cash Per Share | -117.98 |
Equity (Book Value) | 267.20B |
Book Value Per Share | 170.57 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 61.13%, with operating and profit margins of 9.48% and 5.45%.
Gross Margin | 61.13% |
Operating Margin | 9.48% |
Pretax Margin | 11.64% |
Profit Margin | 5.45% |
EBITDA Margin | 21.98% |
EBIT Margin | 9.48% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.15%.
Dividend Per Share | 0.50 |
Dividend Yield | 0.15% |
Dividend Growth (YoY) | -66.67% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.11% |
Shareholder Yield | 0.04% |
Earnings Yield | 1.97% |
FCF Yield | n/a |
Stock Splits
The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.
Last Split Date | Jun 12, 2019 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |